A budget impact analysis published in the Canadian Journal of Cardiology compared the use of surgical (SAVR) versus catheter-based transcatheter aortic valve replacement (TAVR)
News | Heart Failure
TAVR is an Affordable and Effective Strategy for Treating Aortic Stenosis Patients

September 14, 2022 — Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized ...

Home September 14, 2022
Home
Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD)
News | PET Imaging
GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...

Home September 14, 2022
Home
Findings reveal AFib patients are fearful of complications from the condition, but not all are treating their AFib quicky after diagnosis
News | Atrial Fibrillation
Biosense Webster AFib Survey Findings Reveal Surprising Patient Behaviors and At-Risk Population Awareness Gaps

September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...

Home September 14, 2022
Home
Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
News | Stroke
Anthos Therapeutics Announces Abelacimab Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with AFib

September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ...

Home September 13, 2022
Home
TherOx Console
News | STEMI
First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients

September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related ...

Home September 13, 2022
Home
Image showing a co-registration of invasive coronary angiography (A), coronary CTA and straight MPR (panel B and C) with CTA cross sections (panel D), corresponding OCT cross sections and longitudinal OCT view (E).
News | SCCT
CCTA Effective in Pre-procedural Planning of Myocardial Revascularization Interventions

September 13, 2022 — The latest expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT) ...

Home September 13, 2022
Home
The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ŌNŌCOR LLC announced.
News | Structural Heart
First-In-Human Use of the ŌNŌ Retrieval System for Percutaneous Removal of an Embolized Leadless Pacemaker from the Right Pulmonary Artery

September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless ...

Home September 13, 2022
Home
DAIC editors outline some highlights of what to expect from this year’s conference.
Feature | TCT | By Melinda Taschetta-Millane
Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference Preview

The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) ...

Home September 12, 2022
Home
Philips Spectral Angio CT suite
News | SPECT-CT
Philips Announces New Milestones in the Development of the World’s First Spectral Detector Angio CT Solution

September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...

Home September 12, 2022
Home
WATCHMAN FLX now the only LAAC technology in the United States that allows for either DAPT or OAC immediately following implantation
News | Left Atrial Appendage (LAA) Occluders
Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option

September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to ...

Home September 12, 2022
Home
Computed tomography 3D surface rendering of the lungs and heart from a patient with pulmonary arterial hypertension demonstrating trachea and major airways (yellow), an enlarged heart (red), enlarged main pulmonary artery (large blue vessel on top of heart) and thinning of the peripheral pulmonary vessels (blue). Marcus Y. Chen, M.D., NHLBI
News | Hypertension
Novel Blood Test Helps Evaluate Severity in Pulmonary Arterial Hypertension, a Rare Lung Disease

September 12, 2022 — Researchers at the National Institutes of Health have found that a novel blood test can be used to ...

Home September 12, 2022
Home
Araz Rawshani, Sahlgrenska Academy at the University of Gothenburg. Photo by Charlotta Sjöstedt
News | Sudden Cardiac Arrest
Cardiac Arrest Survival Rate Rising

September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30 ...

Home September 09, 2022
Home
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip lock malfunctions with MitraClip Clip Delivery Systems manufactured by Abbott.
News | Heart Valve Technology
FDA Alerts Healthcare Providers to Potential for Clip Lock Malfunctions in Abbott MitraClip Device

September 9, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip ...

Home September 09, 2022
Home
Results from ENVISAGE-TAVI AF show mortality risk score for AFib patients undergoing TAVR. Image courtesy of Mount Sinai Health System
News | Atrial Fibrillation
New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement

September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...

Home September 09, 2022
Home
investigator Michelle O’Donoghue, MD, MPH, a senior investigator of the TIMI Study Group in the Division of Cardiovascular Medicine. Image courtesy of Michelle O'Donoghue/Brigham and Women's Hospital
News | Cardiovascular Clinical Studies
FOURIER-OLE Trial Finds that Long-term Use of Evolocumab Further Reduced Cardiovascular Events

September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...

Home September 08, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now